In this video, Dharam Kaushik, MD, discusses the favorable outcomes of perioperative yoga in patients with prostate cancer. This study was presented recently at the 2021 American Urological Association Annual Meeting. Kaushik is an associate professor and chair of urologic research in the department of urology and the program director of Urologic Oncology Fellowship at the University of Texas Health, San Antonio
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.